Senior Medical Science Liaison, Solid Tumor – Oncology Expert

BeOne Medicines; Kuala Lumpur; On-site; MYR 180,000 - 260,000; Full time

Benefits offered by this job

Market-competitive pay

Shares grant

Learning & development

Great benefits

Collaborative team culture

Job summary

BeOne Medicines in Malaysia is seeking a Medical Science Liaison (MSL) to be a field-based scientific expert. You will build trusted peer-to-peer relationships with KOLs, HCPs, researchers, and other stakeholders, delivering high-quality medical information and strategic insights to support oncology programs.

The role requires deep therapeutic area knowledge, strong scientific communication, and collaboration with Medical Affairs, Regulatory, Market Access and Clinical Operations to advance

Qualifications

• Requires Medical Degree (MBBS/MD), Pharmacy Degree (BPharm/MPharm/PharmD) or PhD.
• Advanced training in oncology or solid tumors preferred.

Responsibilities

• Engage with oncologists, HCPs, researchers and stakeholders to share scientific data.
• Support medical education initiatives and advisory boards.
• Capture and communicate medical insights to inform strategies and evidence needs.
• Identify opportunities for local evidence generation and investigator-initiated studies.
• Ensure compliant, non-promotional scientific exchange with external parties.

Skills

Scientific communication

Stakeholder engagement

Medical affairs

Oncology knowledge

Cross-functional collaboration

Education

Medical Degree or Life Sciences

Tools

Publication planning

Real-world evidence

Job description

BeOne Medicines in Malaysia is seeking a Medical Science Liaison (MSL) to be a field-based scientific expert. You will build trusted peer-to-peer relationships with KOLs, HCPs, researchers, and other stakeholders, delivering high-quality medical information and strategic insights to support oncology programs.

The role requires deep therapeutic area knowledge, strong scientific communication, and collaboration with Medical Affairs, Regulatory, Market Access and Clinical Operations to advance